Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al.

Autor: García-Foncillas J; University Cancer Institute & The Department of Oncology, University Hospital Fundacion Jimenez Diaz, Autonomous University, Madrid, Spain. Electronic address: jgfoncillas@gmail.com., Arnold D; Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany., Avouac B; C2A, Paris, France., Lassen U; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laurent-Puig P; Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Taieb J; Georges Pompidou European Hospital SIRIC-CARPEM, Université Paris Cité, Paris, France., Helland Å; Division of Cancer Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway., Stenzinger A; Institute of Pathology and Center for Personalized Medicine (ZPM), University Hospital Heidelberg, Heidelberg, Germany.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 677-678. Date of Electronic Publication: 2024 May 07.
DOI: 10.1016/j.annonc.2024.04.008
Databáze: MEDLINE